母亲高龄对儿童早期眼科疾病负担的独立影响有限:全国性人群队列研究
该研究基于全国健康保险数据库250万余对母婴,随访至5岁,评估高龄产妇对儿童眼科疾病、侵入性操作及医疗费用的独立影响。结果显示,在足月/正常出生体重儿中,高龄母亲与复合眼科疾病风险略低相关(aHR 0.93),但早产/低出生体重是全部眼科风险的主要驱动因素(HR 1.52-1.81),高龄并非儿童早期眼科疾病的独立生物学决定因素。
要点
- 足月/正常出生体重儿中,高龄母亲与复合眼科疾病风险降低相关(aHR 0.93),主要由斜视风险降低驱动。
- 早产/低出生体重是眼科疾病风险(HR 1.52-1.81)和侵入性操作(IRR 1.84-2.00)的主要驱动因素。
- 足月儿中高龄组ROP诊断率较高(aHR 1.331),但未伴随ROP相关侵入性治疗增加。
核心结论
- 高龄产妇并非儿童早期眼科疾病或需治疗疾病的独立生物学决定因素。
- 在没有早产或低出生体重的情况下,高龄母亲所生子女的早期眼科疾病风险未增加。
研究设计与样本
- 全国性、基于人群的队列研究,纳入2500044对母婴,随访至5岁。
- 其中365494对母婴有详细母亲代谢和生活方式数据,用于控制混杂。
主要发现
- 足月/正常出生体重儿中,高龄与复合眼科疾病风险降低相关(aHR 0.93;95%CI 0.92-0.94),主要由斜视风险降低驱动。
- 足月/正常出生体重儿中,高龄组ROP诊断率较高(aHR 1.331;95%CI 1.211-1.450),但未伴随ROP相关侵入性治疗增加。
- 早产/低出生体重是全部眼科风险(HR 1.52-1.81)和侵入性操作(IRR 1.84-2.00)的主要驱动因素,与母亲年龄无关。
- 不同母亲年龄组间眼科相关医疗费用的差异在调整母亲代谢健康后减弱且不再显著。
关键数值与推荐
- 母亲年龄分组:<35岁 vs ≥35岁;出生状态分组:足月/正常出生体重 vs 早产或低出生体重。
- 复合眼科疾病包括弱视、斜视、先天性白内障。
临床怎么用
- 咨询时应强调围产期健康状况(如早产、低出生体重)而非母亲年龄本身作为儿童早期眼科风险的重点。
- 对高龄母亲所生足月/正常出生体重儿,可提供循证 reassurance,无需因母亲年龄而增加眼科筛查强度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the independent effect of advanced maternal age (AMA) on pediatric ophthalmic morbidity, invasive interventions, and healthcare costs. DESIGN: Nationwide, population-based cohort study PARTICIPANTS: A total of 2,500,044 mother-infant pairs from a national health insurance database, followed from birth to 5 years of age. A health-screening subgroup of 365,494 pairs with detailed maternal metabolic and lifestyle data was analyzed to control for potential confounding. METHODS: Mother-infant pairs were categorized by maternal age (<35 vs ≥ 35 years) and birth status (term/normal birth weight [NBW] vs preterm or low birth weight [LBW]). Cox proportional hazards models and Poisson or negative binomial regression models were used to estimate adjusted hazard ratios (HRs) and incidence rate ratios (IRRs) for ophthalmic outcomes, invasive procedures, and healthcare utilization. Models were sequentially adjusted for neonatal factors, socioeconomic status, maternal comorbidities, and maternal metabolic and lifestyle variables. MAIN OUTCOMES MEASURES: Composite ophthalmic morbidity (amblyopia, strabismus, congenital cataract), retinopathy of prematurity (ROP), invasive ophthalmic procedures, ophthalmic outpatient visits, hospitalizations, and ophthalmology-related healthcare costs. RESULTS: Among Term/NBW infants, older maternal age was associated with a lower risk of composite ophthalmic morbidity (adjusted HR, 0.93; 95% CI, 0.92-0.94), primarily driven by a reduced hazard of strabismus. However, this did not translate into reductions in invasive procedures or hospitalization rates. In contrast, Preterm/LBW status was the primary driver of all ophthalmic risks (HRs 1.52-1.81) and procedures (IRRs 1.84-2.00) regardless of maternal age. Among term/NBW infants, higher ROP diagnosis rates observed in the AMA group (adjusted HR 1.331; 95% CI, 1.211-1.450) were not accompanied by increased ROP-related invasive treatment. Apparent differences in ophthalmology-related healthcare costs across maternal age groups were attenuated and no longer significant after adjustment for maternal metabolic health. CONCLUSIONS: Advanced maternal age is not an independent biological determinant of early pediatric ophthalmic disease or treatment-requiring morbidity. In the absence of prematurity or low birth weight, children born to older mothers are not at increased risk of early ophthalmic disorders. These findings provide evidence-based reassurance for older mothers and support counseling that emphasizes perinatal health status rather than maternal age itself.
引用
- Kang S, Lee S, Park GU, et al. Limited Independent Impact of Maternal Age on Early Childhood Ophthalmic Morbidity: A Nationwide Population-Based Cohort Study. Am J Ophthalmol. 2026. PMID: 42162815. doi:10.1016/j.ajo.2026.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。